Access to anti-retroviral drugs, male in Singapore
Singapore: Access to anti-retroviral drugs, male was 86.0% in 2023. ◆ Volatile
Access to anti-retroviral drugs, male in Singapore, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, male in Singapore stood at 86.0%. That is the highest value across all 24 years on record.
The figure is up 1.2% on the previous year and up 30.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Singapore peaked at 86.0% in 2023 and was at its lowest, 8.0%, in 2000.
That places Singapore 30th out of 141 countries with data for 2023, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Singapore, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 8.0% | — |
| 2001 | 8.0% | +0.0% |
| 2002 | 9.0% | +12.5% |
| 2003 | 9.0% | +0.0% |
| 2004 | 10.0% | +11.1% |
| 2005 | 13.0% | +30.0% |
| 2006 | 20.0% | +53.8% |
| 2007 | 27.0% | +35.0% |
| 2008 | 36.0% | +33.3% |
| 2009 | 45.0% | +25.0% |
| 2010 | 53.0% | +17.8% |
| 2011 | 59.0% | +11.3% |
| 2012 | 63.0% | +6.8% |
| 2013 | 66.0% | +4.8% |
| 2014 | 73.0% | +10.6% |
| 2015 | 76.0% | +4.1% |
| 2016 | 77.0% | +1.3% |
| 2017 | 81.0% | +5.2% |
| 2018 | 81.0% | +0.0% |
| 2019 | 83.0% | +2.5% |
| 2020 | 85.0% | +2.4% |
| 2021 | 85.0% | +0.0% |
| 2022 | 85.0% | +0.0% |
| 2023 | 86.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.5% | 8.0% | 45.0% | 10 |
| 2010s | 71.2% | 53.0% | 83.0% | 10 |
| 2020s | 85.2% | 85.0% | 86.0% | 4 |
Countries ranked near Singapore
More gender data for Singapore
- Child population (UN estimates and projections) 724.18 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.914 % change on previous year (2030)
- Population 5,307 (2030)
- Working-age population (UN estimates and projections) 5,307 (2030)
- Population (UN estimates and projections), annual growth rate 0.3921 % change on previous year (2030)
- Age population, age 00, female, interpolated 23,989 (2025)
- Age population, age 00, male, interpolated 25,420 (2025)
- Age population, age 01, female, interpolated 23,551 (2025)
- Age population, age 01, male, interpolated 24,949 (2025)
- Age population, age 02, female, interpolated 22,853 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Singapore?
- Access to anti-retroviral drugs, male in Singapore was 86.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Singapore?
- The highest recorded value was 86.0% in 2023.
- What is the lowest access to anti-retroviral drugs, male recorded in Singapore?
- The lowest recorded value was 8.0% in 2000.
- How does Singapore rank for access to anti-retroviral drugs, male?
- Singapore ranks 30th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, male rising or falling in Singapore?
- Over the last ten years it is up 30.3%. The long-run trend across the full record is volatile.
- Where does this Singapore data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.